Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

gel-e

gel-e
2007 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$3.1M LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of a hemostatic materials designed to offer a disruptive innovation in the management of human bleeding. The company's hemostatic materials us safe, naturally occurring biomaterials, which offers an advanced wound treatment that requires little-to-no prep time and is extremely quick, can be used in wound treatments with a variety of applications and offers surgical gels to bandages for patients on blood-thinners experiencing routine nuisance bleeds, enabling users to get products that are engineered to stop bleeding quickly and conveniently.

Website
Formerly Known As
Remedium Technologies
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Therapeutic Devices
Primary Office
  • 387 Technology Drive
  • Suite 3110B
  • College Park, MD 20742
  • United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore gel-e’s full profile, request a free trial.

gel-e Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 13-Jul-2017 $3.1M 00.000 Completed Generating Revenue
6. Seed Round 01-Nov-2016 00.000 00.000 00.000 Completed Generating Revenue
5. Accelerator/Incubator 26-Feb-2014 00000 00000 Completed Generating Revenue
4. Grant 00000 0000 Completed Generating Revenue
3. Grant 18-Jan-2013 00000 0000 Completed Generating Revenue
2. Grant 18-Nov-2011 $150K $75K Completed Startup
1. Early Stage VC 05-Sep-2010 $75K $75K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

gel-e Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Seed 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
To view this company’s complete Cap Table, request access »

gel-e Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
UM Ventures Other Minority 000 0000 000000 0
Robin Hood Ventures Angel Group Minority 000 0000 000000 0
Maryland Industrial Partnerships Accelerator/Incubator Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

gel-e Executive Team (6)

Name Title Board
Seat
Contact
Info
Larry Tiffany JD Chairman & President
Rich Vincent Chief Financial Officer
Matthew Dowling Ph.D Co-Founder, Chief Scientific Officer & Board Member
Kevin Smith Executive Vice President, Business Development
Srinivasa Raghavan Ph.D Co-Founder & Advisor

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

gel-e Board Members (4)

Name Representing Role Since Contact
Info
Alexander Arrow Self Board Member 000 0000
James Buck Self Board Member 000 0000
Larry Tiffany JD gel-e Chairman & President 000 0000
Matthew Dowling Ph.D gel-e Co-Founder, Chief Scientific Officer & Board Member 000 0000